Autori: Pour Ludek
Naslov | Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study (Article) |
Autori | Pour Ludek ... Bila Jelena S ... (broj koautora 16) |
Info | HAEMATOLOGICA, (2024), vol. 109 br. 3, str. 895-905 |
Projekat | [NCT04649060] |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S Schjesvold Fredrik Spicka Ivan Maisnar Vladimir Jurczyszyn Artur Grudeva-Popova Zhanet Hajek Roman Usenko Hanna Thuresson Marcus Norin Stefan Jarefors Sara Richardson Paul Pour Ludek |
Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
Ispravka | ISI/Web of Science Elečas Rang časopisa |